Vaccine effectiveness against severe COVID-19 during the Omicron wave in Germany: results from the COViK study

被引：6

作者：

Stoliaroff-Pepin, Anna ^{[1
]}

Peine, Caroline ^{[1
]}

Herath, Tim ^{[1
]}

Lachmann, Johannes ^{[1
]}

Hellenbrand, Wiebke ^{[1
]}

Perriat, Delphine ^{[1
]}

Doerre, Achim ^{[2
]}

Nitsche, Andreas ^{[3
,4
]}

Michel, Janine ^{[3
,4
]}

Grossegesse, Marica ^{[3
,4
]}

Hofmann, Natalie ^{[3
,4
]}

Rinner, Thomas ^{[3
,4
]}

Kohl, Claudia ^{[3
,4
]}

Brinkmann, Annika ^{[3
,4
]}

Meyer, Tanja ^{[5
]}

Stern, Daniel ^{[5
]}

Treindl, Fridolin ^{[5
]}

Dorner, Brigitte G. ^{[5
]}

Hein, Sascha ^{[6
]}

Werel, Laura ^{[6
]}

Hildt, Eberhard ^{[6
]}

Glaeser, Sven ^{[7
]}

Schuehlen, Helmut ^{[8
]}

Isner, Caroline ^{[9
]}

Peric, Alexander ^{[10
]}

Ghouzi, Ammar ^{[11
]}

Reichardt, Annette ^{[12
]}

Janneck, Matthias ^{[13
]}

Lock, Guntram ^{[14
]}

Huster, Dominik ^{[15
]}

Gruenewald, Thomas ^{[16
]}

Schaade, Lars ^{[17
]}

Wichmann, Ole ^{[1
]}

Harder, Thomas ^{[1
]}

机构：

[1] Robert Koch Inst, Dept Infect Dis Epidemiol, Immunizat Unit, Berlin, Germany

[2] Robert Koch Inst, Dept Infect Dis Epidemiol, Berlin, Germany

[3] Robert Koch Inst, Ctr Biol Threats & Special Pathogens, WHO Reference Lab SARS CoV 2, ZBS1 Highly Pathogen Viruses, Berlin, Germany

[4] Robert Koch Inst, WHO Collaborating Ctr Emerging Infect & Biol Thre, ZBS1 Highly Pathogen Viruses, Berlin, Germany

[5] Robert Koch Inst, Ctr Biol Threats & Special Pathogens, ZBS3 Biol Toxins, Berlin, Germany

[6] Paul Ehrlich Inst, Div Virol, Paul Ehrlich Str 51-59, D-63225 Langen, Germany

[7] Vivantes Klinikum Neukolln & Spandau, Klin Innere Med Pneumol & Infektiol, Berlin, Germany

[8] Vivantes Netzwerk Gesundheit GmbH, Direktorat Klin Forsch & Akad Lehre, Berlin, Germany

[9] Vivantes Auguste Viktoria Klinikum, Klin Innere Med Infektiol, Rubensstr 125, D-12157 Berlin, Germany

[10] Vivantes Klinikum Friedrichshain, Klin Pneumol & Infektiol, Landsberger Allee 49, D-10249 Berlin, Germany

[11] Schon Klin Dusseldorf, Interdisziplinare Notaufnahme, Heerdter Krankenhaus 2, D-40549 Dusseldorf, Germany

[12] Helios Klinikum Berlin Buch, Schwanebecker Chaussee 50, D-13125 Berlin, Germany

[13] Albertinen Krankenhaus, Klin Kardiol, Sekt Nephrol, Suntelstr 11a, D-22457 Hamburg, Germany

[14] Albertinen Krankenhaus, Klin Innere Med, Suntelstr 11a, D-22457 Hamburg, Germany

[15] Helios Klinikum Erfurt, Klin Innere Med, Erfurt, Germany

[16] Klinikum Chemnitz, Klin Infekt & Tropenmed, Chemnitz, Germany

[17] Robert Koch Inst, Ctr Biol Threats & Special Pathogens, Berlin, Germany

来源：

INFECTION | 2023年 / 51卷 / 04期

关键词：

COVID-19; Vaccine effectiveness; Hospitalization; Case-control study; SARS-CoV-2; Omicron;

D O I：

10.1007/s15010-023-02012-z

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

PurposeCOViK, a prospective hospital-based multicenter case-control study in Germany, aims to assess the effectiveness of COVID-19 vaccines against severe disease. Here, we report vaccine effectiveness (VE) against COVID-19-caused hospitalization and intensive care treatment during the Omicron wave.MethodsWe analyzed data from 276 cases with COVID-19 and 494 control patients recruited in 13 hospitals from 1 December 2021 to 5 September 2022. We calculated crude and confounder-adjusted VE estimates.Results21% of cases (57/276) were not vaccinated, compared to 5% of controls (26/494; p < 0.001). Confounder-adjusted VE against COVID-19-caused hospitalization was 55.4% (95% CI: 12-78%), 81.5% (95% CI: 68-90%) and 95.6% (95%CI: 88-99%) after two, three and four vaccine doses, respectively. VE against hospitalization due to COVID-19 remained stable up to one year after three vaccine doses.ConclusionThree vaccine doses remained highly effective in preventing severe disease and this protection was sustained; a fourth dose further increased protection.

引用

页码：1093 / 1102

页数：10

共 50 条

[1] Vaccine effectiveness against severe COVID-19 during the Omicron wave in Germany: results from the COViK study
Anna Stoliaroff-Pepin
Caroline Peine
Tim Herath
Johannes Lachmann
Wiebke Hellenbrand
Delphine Perriat
Achim Dörre
Andreas Nitsche
Janine Michel
Marica Grossegesse
Natalie Hofmann
Thomas Rinner
Claudia Kohl
Annika Brinkmann
Tanja Meyer
Daniel Stern
Fridolin Treindl
Brigitte G. Dorner
Sascha Hein
Laura Werel
Eberhard Hildt
Sven Gläser
Helmut Schühlen
Caroline Isner
Alexander Peric
Ammar Ghouzi
Annette Reichardt
Matthias Janneck
Guntram Lock
Dominik Huster
Thomas Grünewald
Lars Schaade
Ole Wichmann
Thomas Harder
[J]. Infection, 2023, 51 : 1093 - 1102
[2] Effectiveness of the Original COVID-19 Vaccine against COVID-19 Exacerbations during the Omicron Wave: A Population-based Study in Okayama, Japan
Matsumoto, Naomi
Mitsuhashi, Toshiharu
Matsuo, Rumi
Kadowaki, Tomoka
Takao, Soshi
Yorifuji, Takashi
[J]. JMA JOURNAL, 2023, 6 (04): : 463 - 469
[3] COVID-19 Vaccine Effectiveness Against Omicron Infection and Hospitalization
Piche-Renaud, Pierre-Philippe
Swayze, Sarah B.
Buchan, Sarah
Wilson, Sarah B.
Austin, Peter Z.
Morris, Shaun
Nasreen, Sharifa E.
Schwartz, Kevin M.
Tadrous, Mina
Thampi, Nisha H.
Wilson, Kumanan E.
Kwong, Jeffrey
[J]. PEDIATRICS, 2023, 151 (04)
[4] Effectiveness of inactivated COVID-19 vaccine against the severity of Omicron variant
Wang, Hao
Liu, Li
Wu, Tangchun
[J]. FRONTIERS OF MEDICINE, 2023, 17 (03) : 576 - 580
[5] Effectiveness of inactivated COVID-19 vaccine against the severity of Omicron variant
Hao Wang
Li Liu
Tangchun Wu
[J]. Frontiers of Medicine, 2023, 17 : 576 - 580
[6] High vaccine effectiveness against severe COVID-19 in the elderly in Finland before and after the emergence of Omicron
Baum, Ulrike
Poukka, Eero
Leino, Tuija
Kilpi, Terhi
Nohynek, Hanna
Palmu, Arto A.
[J]. BMC INFECTIOUS DISEASES, 2022, 22 (01)
[7] Vaccine effectiveness of CoronaVac against COVID-19 among children in Brazil during the Omicron period
Florentino, Pilar T., V
Alves, Flavia J. O.
Cerqueira-Silva, Thiago
Oliveira, Vinicius de Araujo
Junior, Juracy B. S.
Jantsch, Adelson G.
Penna, Gerson O.
Boaventura, Viviane
Werneck, Guilherme L.
Rodrigues, Laura C.
Pearce, Neil
Barral-Netto, Manoel
Barreto, Mauricio L.
Paixao, Enny S.
[J]. NATURE COMMUNICATIONS, 2022, 13 (01)
[8] High vaccine effectiveness against severe COVID-19 in the elderly in Finland before and after the emergence of Omicron
Ulrike Baum
Eero Poukka
Tuija Leino
Terhi Kilpi
Hanna Nohynek
Arto A. Palmu
[J]. BMC Infectious Diseases, 22
[9] Vaccine effectiveness of CoronaVac against COVID-19 among children in Brazil during the Omicron period
Pilar T. V. Florentino
Flávia J. O. Alves
Thiago Cerqueira-Silva
Vinicius de Araújo Oliveira
Juracy B. S. Júnior
Adelson G. Jantsch
Gerson O. Penna
Viviane Boaventura
Guilherme L. Werneck
Laura C. Rodrigues
Neil Pearce
Manoel Barral-Netto
Mauricio L. Barreto
Enny S. Paixão
[J]. Nature Communications, 13
[10] Author Correction: Effectiveness of mRNA COVID-19 vaccine booster doses against Omicron severe outcomes
Ramandip Grewal
Lena Nguyen
Sarah A. Buchan
Sarah E. Wilson
Sharifa Nasreen
Peter C. Austin
Kevin A. Brown
Deshayne B. Fell
Jonathan B. Gubbay
Kevin L. Schwartz
Mina Tadrous
Kumanan Wilson
Jeffrey C. Kwong
[J]. Nature Communications, 14

← 1 2 3 4 5 →